Consumer group Community Catalyst announced its second annual Bitter Pill Awards, skewering the makers of Ambien, Lunesta and Strattera, among others, for what it deems to be irresponsible marketing practices.
Xchange makes three new hires, one promotion
June 1, 2006
4:43 pm
Xchange, the relationship-marketing unit of CommonHealth, has made three new hires and a promotion.
Healthpoint names new VP of sales
June 1, 2006
4:39 pm
Healthpoint has named Jay Speelhoffer VP of sales for the pharmaceutical company’s tissue management division.
AstraZeneca, Biovail enter into agreement for Zoladex
June 1, 2006
4:28 pm
AstraZeneca and Biovail have entered into an agreement in which Biovail’s specialty sales force will promote AstraZeneca’s Zoladex (goserelin acetate implant) to obstetricians and gynecologists for the treatment of endometriosis in the US and Puerto Rico.
AstraZeneca won’t advertise its new indication
June 1, 2006
8:35 pm
AstraZeneca will not run TV or print ads for its recently approved pediatric indication on Nexium.
Most pharmaceutical sales reps believe PhRMA’s Code on Interactions with Healthcare Professionals is negatively impacting their jobs, according to a recent study by market research firm G&S.
CHC calls for simpler DTC guidelines
May 1, 2006
9:12 pm
The Coalition for Healthcare Communications (CHC) called on the FDA to simplify guidelines for DTC advertising.